ANGO

AngioDynamicsA

Nasdaq / Health Care Equipment & Services

At close

2026-07-18

View Chart

Curated Events

Active

Recent Headlines

New

Curated events

Materiality

earnings

Source

External coverage

Decided

2026-07-14

AngioDynamics Reports Fiscal Year 2026 Third Quarter Financial Results; Sustained Double-Digit Med Tech Growth Drives Continued Profitability

Positive issuer-level earnings signal: AngioDynamics reports sustained double-digit med-tech growth and continued profitability.

View event details3 more curated

Sentiment decomposition

+30.0

30-day score

Company-55%

Macro+30.030%

Pulse-15%

The 30-day sentiment score is a decayed blend of Company, Macro, and Pulse components.

Recent headlines

Headline

Time

Relevance

AngioDynamics Inc (ANGO) Q4 2026 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges

2026-07-14

13%

External coverage

AngioDynamics Tops Revenue Forecasts and Raises Sales Outlook for Fiscal 2027 (ANGO)

2026-07-14

72%

External coverage

AngioDynamics: Fiscal Q4 Earnings Snapshot

2026-07-14

13%

External coverage

AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability

2026-07-14

13%

External coverage

AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026

2026-06-30

External coverage

AngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH)

2026-06-17

28%

External coverage

AngioDynamics Inc (ANGO) Q3 2026 Earnings Call Highlights: Strong Revenue Growth Amid Financial ...

2026-04-02

13%

External coverage

As of 2026-06-30 • Updated scheduledSource: News desk